What CNRS Innovation does

CNRS Innovation is the technology transfer and commercialization arm of CNRS (Centre National de la Recherche Scientifique), France's largest public fundamental research organization. It operates as a for-profit operational unit headquartered at 79 Avenue Edouard Vaillant, Boulogne-Billancourt, with 51–100 employees, and holds ISO 9001:2015 certification from SOCOTEC Certification France covering IP protection, innovative project development, startup creation, and technology transfer. The organization manages the licensing and exploitation of CNRS laboratory IP across five principal domains: diagnostic medical, chemistry, materials/coatings, environment/energy, and mechanics, with a catalogue spanning technologies such as cancer biomarker diagnostics, enzymatic biofuel cells, sodium-ion battery anodes, MOF catalysts for deNOx and hydrocarbon separation, graphene production processes, and carbon-nanotube filtration membranes.

The organization runs two flagship programs: the Prématuration program (since 2014), which provides early-stage funding and accompaniment to mature research projects toward commercial readiness, and the RISE startup acceleration program (since 2019), which supports the creation and growth of startups from CNRS research, currently hosting its 15th promotion (12 projects, summer 2026). Its 2024 activity report cites 450+ exploitation contracts signed since 2012, 1,500+ projects in prématuration, and 800+ startups supported via RISE. The revenue model is built on licensing royalties, exploitation contracts, and equity participation in supported startups (the contact form explicitly lists "Participation au capital de start-up" as an inquiry category). Commercial reach is achieved through strategic co-development partnerships—most notably a renewed five-year deal with SUEZ in 2025 covering water and decarbonization technologies, building on 30+ prior cooperative projects and 14 shared patents—and through recurring industry-event presence such as the Cosmetic 360 trade show with Cosmetic Valley (since 2015). Named portfolio companies referenced on the website include Cardiawave, Aenitis, Medsenic, Novimet, Greenerwave, Sensome, Supersonic Imagine, Crocus, and Netris Pharma.

Name

CNRS Innovation

Legal name

CNRS Innovation

Website

https://cnrsinnovation.com

Company type

Private

Founded year

2012

Operating status

Operating

Headcount range

51–100 employees

Short description

CNRS Innovation is the technology transfer office of CNRS, France's largest public research organization, managing IP licensing, patent exploitation, and startup creation (RISE program, Prématuration program) across diagnostic medical, chemistry, materials, energy, and mechanics domains for industrial partners and academic entrepreneurs.

Ownership category

akta.pro rank

Product category

Technology Transfer Services

NAICS

Scientific Research and Development Services (5417)

akta.pro primary industry

Science, Technology & Innovation Administration (National R&D Policy) (BPAIAAAK)

akta.pro secondary industry

Corporate Venture Studios & Incubators (Build/launch ventures) (FSANAHAC)

Keywords

• Technology transfer services
• Patent licensing
• Research commercialization
• Startup incubation
• Intellectual property management

Headquarters

HQ city

Boulogne-billancourt

HQ country

France

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D

Revenue model

1. Technology Transfer and Licensing: Management of exploitation contracts, patent licensing, and technology transfer from CNRS research to industry partners

Go-to-market motion1 record

Distribution channels3 records

Marketing channels2 records

Core offering

CNRS Innovation is the technology transfer office of CNRS (Centre National de la Recherche Scientifique), managing commercialization of research innovations developed in CNRS laboratories. The organization operates the Prématuration program for early-stage project development (since 2014), the RISE startup acceleration program (since 2019), and licenses a portfolio of patents across diagnostic medical, chemistry, materials/coatings, environment/energy, and mechanics domains to industrial partners.

Product overview

CNRS Innovation is the technology transfer office of CNRS (French National Centre for Scientific Research), managing a portfolio of patents and technologies developed by CNRS laboratories across France. The organization operates as a platform connecting basic research with industry applications, offering programs including RISE (startup acceleration since 2019) and Prématuration (early-stage project development since 2014). The technology portfolio spans multiple domains including diagnostic medical technologies (cancer biomarkers, biosensors, imaging nanoparticles), energy solutions (biofuel cells, sodium-ion batteries, supercapacitors), chemistry (MOF catalysts, click chemistry compounds, CNT technologies), and advanced materials (graphene, photoinitiators, nano-composites). The organization facilitates technology licensing and transfer to industrial partners seeking innovation from French public research.

Differentiator

Problem solved

Functional benefit

Products and services

• RISE Program Startup acceleration program that supports innovative projects from CNRS laboratories, providing mentorship, resources, and accompaniment for technology startup creation. Targeted at researchers and entrepreneurs commercializing CNRS research.
• Prématuration Program Pre-maturation program supporting early-stage technology development projects from CNRS laboratories, providing accompaniment and resources to mature research innovations toward commercial readiness. Targeted at CNRS research teams.
• Methods for Predicting Sensitivity of Renal Cancer Subjects to Cancer Treatment Diagnostic method using CXCL5 and CXCL7 expression levels to predict patient sensitivity to tyrosine kinase inhibitors and antibodies for metastatic clear cell renal cell carcinoma treatment. Available for licensing to industrial partners.
• Glucose Biofuel Cell Pad Metal-free enzymatic biofuel cell shaped as a button cell using glucose as fuel, designed for portable electronic devices, medical tests, and disposable sensors. Available for licensing to industrial partners.
• Electrosynthesis of Redox Mediators for Enzymatic Glucose Oxidation Nanostructured bioelectrodes for glucose oxidation using electrogenerated aromatic compound mediators for improved electron transfer in biofuel cells and glucose biosensors. Available for licensing to industrial partners.
• Alpha-Hydroxy-Beta-Triazolo-Tetrazole for Click-Chemistry Chemical compounds enabling two successive CuAAC (copper-catalyzed azide-alkyne cycloaddition) reactions for modular chemical synthesis in bioconjugation, photovoltaics, and medicinal chemistry applications. Available for licensing.
• New Photoinitiator Based on Bifunctional Silane Bifunctional silane-based photoinitiators combining grafting and photoinitiation functions for improved silica-polymer coupling in photopolymerizable composite materials. Available for licensing.
• New Anode Materials for Na-ion Batteries Intermetallic anode materials for sodium-ion batteries offering better electrochemical performance than lithium-ion equivalents, with no toxic or rare elements. Available for licensing.
• Large Size and High Quality Graphene on Silicon Process for controlled graphene layer growth on silicon carbide substrates for NEMS, MEMS, sensors, and high-frequency transistors applications. Available for licensing.
• MOF Application: deNOx Catalysis Porous metal-organic framework catalysts for nitrogen oxide reduction (deNOx) in gaseous or liquid effluents at room temperature. Available for licensing.
• MOF Application: Hydrocarbons Separation Metal-organic frameworks for separation of olefin/paraffin mixtures and molecules with different unsaturation degrees in petrochemical applications. Available for licensing.
• Application of CNT onto Hollow Fiber Polymeric Materials for Filtration Carbon nanotube membranes on industrial hollow fiber polymers for water filtration, resisting backwashing while removing micro-pollutants, viruses, and heavy metals. Available for licensing.
• Biphotonic Photosensitizers and Nanoparticles Silica nanoparticles functionalized with biphotonic photosensitizers for targeted photodynamic cancer therapy with reduced photosensitizer leakage. Available for licensing.
• Persistent Luminescence Nanoparticles for In Vivo Imaging Persistent luminescence nanoparticles excitable in situ for real-time optical imaging and bimodal optical/MRI imaging with theranostic applications. Available for licensing.
• AequorinXS and Redquorin XS Calcium Biosensors Genetically mutated aequorin-based biosensors with enhanced calcium sensitivity and improved bioluminescence intensity for cellular imaging, drug screening, and in vivo applications. Available for licensing.
• Novel Recombinant Lectins for Detection of Pathological State Markers Recombinant multimeric lectins with beta-propeller architecture for detecting aberrant glycosylation in cancer diagnostics and disease biomarker detection. Available for licensing.
• Graphene Solution Process for graphene sheet production by reduction of graphite, enabling surfactant-free and ultrasound-free processing for nanoelectronics applications. Available for licensing.
• CNT Reinforced 3D Composites Carbon nanotubes reinforced 3D composite materials using CVD-grown CNTs on microfillers for enhanced mechanical and functional properties in aeronautics and energy applications. Available for licensing.
• Carbon Fibers Reinforced with Carbon Nanotubes Hybrid nano/micro filler materials combining CNTs with traditional microfillers for improved mechanical, thermal, and electrical properties in structural composites. Available for licensing.
• Enzymatic Supercapacitor for Implementable Medical Devices Sugar-based electrochemical supercapacitor charged by converting biological materials like blood glucose for implantable medical device power supply. Available for licensing.
• Tungsten Oxide-Based Hole Transport Layer for OPV Tungstate ion-based hole transport layer with improved stability for organic photovoltaic and OLED devices, replacing PEDOT:PSS. Available for licensing.

Quantifiable outcome

• Multiple exploitation contracts signed since 2012
• +2 more outcomes

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Partnerships

Two partnerships are on record, tiered core and minor.

• SUEZcoreStrategic or Co-development Partner · 1 January 2025Five-year strategic partnership established in 2025 for sustainable water and decarbonization technologies. The partnership builds on over 30 cooperative projects history with 14 shared patents. Includes industrial-scale pilot at the Terre d'Aquitaine site in Saint-Selve for water research applications.
• Cosmetic ValleyminorGTM or Marketing Partner · 1 January 2015Partnership for participation in Cosmetic 360 trade show since 2015, promoting cosmetics-related research technologies and innovations from CNRS laboratories.

Scale indicators5 records

Recent moves6 records

Expansion highlights4 records

Direct peers

• Fraunhofer Society: Germany's largest applied research organization, operating ~75 institutes with a model combining contract research, licensing, and spinout creation. Closest European analog to CNRS Innovation's tech-transfer-plus-incubation operating model at national scale.
• Cambridge Enterprise: University tech transfer office for the University of Cambridge, offering IP licensing, seed funding, and startup incubation. Closest UK university analog with similar spinout volume and licensing operations.
• CEA (Commissariat à l'énergie atomique et aux énergies alternatives): French government research organization with its own dedicated technology transfer and industrial partnerships arm operating across energy, materials, and life sciences. Highly comparable as a peer French state research body that commercializes public research IP.
• Imperial College Innovations: Tech transfer and startup creation function for Imperial College London, handling IP licensing and spinout support across engineering, medicine, and physical sciences. Comparable European university tech-transfer peer.
• Helmholtz Association: Germany's largest scientific organization with 18 research centers and dedicated technology transfer and industry-licensing functions. Comparable European public-research commercialization entity at multi-domain scale.
• INRIA (Institut national de recherche en sciences et technologies du numérique): French national institute for digital science research with its own technology transfer and startup creation function (INRIA Startup Studio). Direct French peer with comparable IP licensing and incubator programs.
• Oxford University Innovation: University tech transfer office for the University of Oxford, managing IP licensing, spinoff formation, and consulting. Comparable scale of exploitation contracts and startup support within a major European research institution.
• Max Planck Innovation: Dedicated tech transfer office for Germany's Max Planck Society, handling patent management, licensing, and spinout creation from one of Europe's largest basic-research portfolios. Same business model and value chain as CNRS Innovation.

Others

• Bpifrance: French public investment bank that co-funds deep-tech startups alongside public research commercialization entities. Indirectly connected via shared startup pipelines and French deep-tech funding ecosystem rather than direct competition.

Regional players

• Institut Pasteur: French biomedical research foundation with technology transfer, licensing, and spinout creation activities in life sciences. Adjacent French peer focused on health/biotech rather than full multi-domain scope.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights6 records

Customer concentration

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments3 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CNRS Innovation